Covered recipient · General Payments record
CHARLES L HARRIS
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2018–2024
$4,631.59
- Reported across 113 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $532.65 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Genentech USA, Inc. | $247.02 | 10 |
| Bausch & Lomb Americas Inc. | $125.00 | 1 |
| Sandoz Inc. | $91.41 | 3 |
| Astellas Pharma US Inc | $44.81 | 2 |
| Harrow Eye, LLC | $24.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $19.44 | 03/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139301392 | CMS |
| Astellas Pharma US Inc | $25.37 | 08/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139374945 | CMS |
| Bausch & Lomb Americas Inc. | $125.00 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140319565 | CMS |
| Genentech USA, Inc. | $29.71 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132986604 | CMS |
| Genentech USA, Inc. | $16.68 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132986608 | CMS |
| Genentech USA, Inc. | $19.65 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132986619 | CMS |
| Genentech USA, Inc. | $26.67 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132986611 | CMS |
| Genentech USA, Inc. | $33.21 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132986615 | CMS |
| Genentech USA, Inc. | $22.14 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132986623 | CMS |
| Genentech USA, Inc. | $11.13 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132986627 | CMS |
| Genentech USA, Inc. | $33.59 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132986635 | CMS |
| Genentech USA, Inc. | $25.85 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132986631 | CMS |
| Genentech USA, Inc. | $28.39 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132986639 | CMS |
| Harrow Eye, LLC | $24.41 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145604640 | CMS |
| Sandoz Inc. | $38.47 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089368196 | CMS |
| Sandoz Inc. | $26.61 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089368200 | CMS |
| Sandoz Inc. | $26.33 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089368240 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.